Nissan Medical Industries Ltd (NISA.TA)
ILA 1160.0
(0.0%)
ILA 1160.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 73.14 Million ILS | -13.99% |
| 2022 | 85.04 Million ILS | 8.18% |
| 2021 | 78.6 Million ILS | 10.38% |
| 2020 | 71.21 Million ILS | 20.93% |
| 2019 | 58.88 Million ILS | 0.0% |
| 2018 | 58.88 Million ILS | -4.84% |
| 2017 | 61.88 Million ILS | 5.31% |
| 2016 | 58.76 Million ILS | -0.22% |
| 2015 | 58.89 Million ILS | 6.7% |
| 2014 | 55.19 Million ILS | 13.15% |
| 2013 | 48.77 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 18.2 Million ILS | -5.4% |
| 2024 Q2 | 17.41 Million ILS | -10.25% |
| 2023 Q2 | 17.55 Million ILS | -4.38% |
| 2023 Q1 | 18.35 Million ILS | -10.14% |
| 2023 Q3 | 17.78 Million ILS | 1.32% |
| 2023 FY | 73.14 Million ILS | -13.99% |
| 2023 Q4 | 19.24 Million ILS | 8.24% |
| 2022 FY | 85.04 Million ILS | 8.18% |
| 2022 Q4 | 20.42 Million ILS | 9.25% |
| 2022 Q3 | 18.69 Million ILS | -9.24% |
| 2022 Q1 | 25.27 Million ILS | 8.01% |
| 2022 Q2 | 20.6 Million ILS | -18.49% |
| 2021 Q1 | 17.3 Million ILS | -3.28% |
| 2021 Q4 | 23.39 Million ILS | 29.76% |
| 2021 FY | 78.6 Million ILS | 10.38% |
| 2021 Q2 | 19.87 Million ILS | 14.87% |
| 2021 Q3 | 18.03 Million ILS | -9.29% |
| 2020 Q1 | 16.21 Million ILS | 8.56% |
| 2020 Q2 | 18.81 Million ILS | 16.05% |
| 2020 Q4 | 17.89 Million ILS | -2.18% |
| 2020 Q3 | 18.29 Million ILS | -2.81% |
| 2020 FY | 71.21 Million ILS | 20.93% |
| 2019 Q2 | 15.3 Million ILS | 6.09% |
| 2019 Q1 | 14.42 Million ILS | -4.74% |
| 2019 FY | 58.88 Million ILS | 0.0% |
| 2019 Q4 | 14.93 Million ILS | 5.06% |
| 2019 Q3 | 14.21 Million ILS | -7.11% |
| 2018 Q3 | 13.88 Million ILS | -5.67% |
| 2018 Q4 | 15.14 Million ILS | 9.12% |
| 2018 Q2 | 14.71 Million ILS | -2.86% |
| 2018 FY | 58.88 Million ILS | -4.84% |
| 2018 Q1 | 15.14 Million ILS | -0.41% |
| 2017 FY | 61.88 Million ILS | 5.31% |
| 2017 Q1 | 17.76 Million ILS | 20.69% |
| 2017 Q2 | 14.77 Million ILS | -16.86% |
| 2017 Q3 | 14.12 Million ILS | -4.37% |
| 2017 Q4 | 15.2 Million ILS | 7.65% |
| 2016 Q3 | 14.75 Million ILS | -3.11% |
| 2016 FY | 58.76 Million ILS | -0.22% |
| 2016 Q4 | 14.72 Million ILS | -0.22% |
| 2016 Q2 | 15.22 Million ILS | 8.36% |
| 2016 Q1 | 14.05 Million ILS | 14.23% |
| 2015 Q2 | 17.06 Million ILS | 8.51% |
| 2015 Q3 | 14.24 Million ILS | -16.54% |
| 2015 FY | 58.89 Million ILS | 6.7% |
| 2015 Q1 | 15.72 Million ILS | -48.49% |
| 2015 Q4 | 12.3 Million ILS | -13.61% |
| 2014 Q1 | 11.87 Million ILS | 76.78% |
| 2014 Q2 | 12.62 Million ILS | 6.31% |
| 2014 Q3 | 23.66 Million ILS | 87.5% |
| 2014 FY | 55.19 Million ILS | 13.15% |
| 2014 Q4 | 30.53 Million ILS | 29.02% |
| 2013 FY | 48.77 Million ILS | 0.0% |
| 2013 Q1 | 12.43 Million ILS | 0.0% |
| 2013 Q2 | 20.54 Million ILS | 65.23% |
| 2013 Q3 | 11.15 Million ILS | -45.7% |
| 2013 Q4 | 6.71 Million ILS | -39.79% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|